Report cover image

Anatomical Modelling Market 2026-2035

Published Mar 31, 2026
Length 264 Pages
SKU # ORMR21117552

Description

Anatomical Modelling Market Size, Share & Business Analysis Report by Type (Physical Models, Digital / Virtual Models, and Services) by Models (Standard Quality Models, High-Fidelity / Premium Models, and Custom & Patient-Specific Models) by End-Use Industry (Hospitals & Clinics, Academic Institutions & Education Centers, Research Centers & Laboratories, Veterinary Clinics / Animal Health, and Others) Forecast Period (2026-2035)

Industry Overview

Anatomical modelling market was valued at $365.0 million in 2025, projected to reach $680.0 million by 2035, growing at a CAGR of 6.4% from 2026 to 2035. The market is expanding steadily due to increasing adoption of simulation-based training in medical and dental education, rising demand for patient-specific surgical planning, and advancements in 3D printing and multi-material manufacturing technologies. Growing emphasis on reducing reliance on cadavers and animal specimens, along with the need for cost-effective and repeatable training solutions, is further supporting market growth. In October 2025, Fundamental VR highlighted growing interest in high-fidelity immersive simulation for cardiology training, particularly in complex intracardiac interventions. According to a recent survey of cardiologists, 68.75% of respondents indicated they would consider adopting immersive simulation for coronary artery procedures, citing potential benefits in improving wire handling, navigation skills, and interpretation of multimodality imaging. The findings indicated certain limitations associated with traditional training approaches, particularly with respect to anatomical realism and tactile feedback. The report further stated that immersive platforms integrating haptic technology, multimodal imaging, and interactive 3D anatomical visualisation have the potential to support clinician education, device evaluation, and improved procedural standardisation.

Market Dynamics

Next-Generation Innovations in Hospitals & Clinical Settings

Hospitals and clinics are accelerating innovation in the anatomical model market by adopting 3D printing and patient-specific models for precise surgical planning. Integration of CT and MRI imaging allows clinicians to rehearse complex procedures and improve outcomes. The growing establishment of in-house medical 3D labs is further boosting demand for high-fidelity, customised anatomical models in clinical care. In January 2026, Clinicians at British Columbia Cancer, Kelowna, introduced a small 3D printer to produce patient-specific brachytherapy applicators, enabling more precise radiation delivery for cervical, vaginal, and recurrent endometrial cancers. Using MRI and CT imaging, the team designs customised tools tailored to individual anatomy, addressing limitations of standard one-size-fits-all devices. In 2025, the centre completed 31 procedures with the custom applicators, supported by funding from the B.C. Cancer Foundation. The initiative has received internal recognition and is being expanded in collaboration with other centres across British Columbia.

Customised and Patient-Specific Anatomical Models

Custom and patient-specific models are a premium segment of the anatomical modelling market, created from CT and MRI data to produce precise 3D replicas of individual anatomy. Manufactured technologies, these models provide greater accuracy than standard versions. Rising adoption of personalised medicine and increasing surgical complexity are key factors driving their global demand. In January 2026, Hospitals worldwide are accelerating the adoption of digital manufacturing technologies to enhance patient care. In the UK, North Bristol NHS Trust launched the Bristol 3D Medical Centre at the former Frenchay Hospital site, integrating 3D printing, high-resolution scanning, and digital modelling to support advanced clinical treatments, including personalised prosthetics for trauma patients.

Market Segmentation
  • Based on type, the market is segmented into physical models, digital/virtual models, and services.
  • Based on models, the market is segmented into standard quality models, high-fidelity/premium models, and custom & patient-specific Models.
  • Based on end-use industry, the market is segmented into hospitals & clinics, academic institutions & education centres, research centres & laboratories, veterinary clinics/animal health, and others.
Academic & Education: A segment in the Market Growth

It’s emerging as a dominant force in the anatomical modelling market, projected to capture a significant share of revenue by 2030 as medical schools pivot toward simulation-based learning. Driven by a surge in global medical enrollments and the integration of 3D-printed and digital hybrid models, institutions are increasingly replacing traditional cadaveric study with high-fidelity, reusable tools. This shift not only addresses the scarcity of biological specimens but also democratises advanced surgical training, fueling a steady market growth. In March 2025, Materialise and the University of Michigan launched an FDA pivotal clinical trial for a groundbreaking bioresorbable 3D-printed tracheobronchial splint designed to treat infants and children with severe airway conditions. The eight-year study, which began in January 2025 at the University of Michigan Health C.S. Mott Children’s Hospital, will enrol at least 35 patients. Developed using Materialise’s Mimics software and biodegradable polycaprolactone material, the implant gradually dissolves in the body and could pave the way for regular clinical use pending FDA approval.

Regional Outlook

The global anatomical modelling market is further divided by region, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

North America is Leading the Global Anatomical Modelling Market

North America continues to dominate the global anatomical modelling market, fueled by rapid advancements in 3D printing and a robust healthcare infrastructure in the United States and Canada. The integration of patient-specific models for complex surgical planning and the expansion of simulation-based medical education drive this leadership. In February 2026, Ricoh Canada Inc. acquired ET Group to strengthen its digital services and hybrid workplace solutions portfolio. The acquisition enhances Ricoh’s enterprise audiovisual integration and managed workplace capabilities, particularly in government and regulated sectors. ET Group will operate as a wholly owned subsidiary, supporting Ricoh’s global expansion strategy and complementing its previous workplace technology acquisitions.

Market Players Outlook

The major companies operating in the global anatomical modelling market include 3B Scientific GmbH, Lardal Medical AS, Stratasys Ltd, GPI Anatomical, and Erler-Zimmer GmbH & Co. KG, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their business and develop innovative models, maintaining their market position.

Recent Developments
  • In September 2025, Anatomy Warehouse announced an exclusive partnership with Erler-Zimmer GmbH & Co. KG to distribute innovative 3D-printed anatomical models across U.S. schools and training facilities. Developed in collaboration with Monash University, the Erler-Zimmer 3D Anatomy Series is created from high-resolution CT and MRI scans, offering near-cadaveric accuracy without ethical or logistical constraints. The nearly 200-model lineup is expected to support medical and nursing programs seeking cost-effective, high-fidelity educational tools.
  • In November 2024, Laerdal Medical, a global leader in healthcare education, training, and therapy solutions, is excited to announce a new partnership with the American Hospital Association (AHA). This collaboration, in conjunction with the AHA’s Patient Safety Initiative, will support efforts to strengthen quality and patient safety in hospitals across the United States. Laerdal Medical and the AHA share common goals to advance equitable care and health improvement for all.
The Report Covers
  • Market value data analysis of 2025 and forecast to 2035.
  • Annualised market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the anatomical modelling market. Based on the availability of data, information related to new products and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

Table of Contents

264 Pages
1. Report Summary
Current Industry Analysis and Growth Potential Outlook
Anatomical Modelling Market Sales Analysis – Type Application End-Use Industry ($ Million)
Anatomical Modelling Market Sales Performance of Top Countries
1.1. Research Methodology
Primary Research Approach
Secondary Research Approach
1.2. Market Snapshot
2. Market Overview and Insights
2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Anatomical Modelling Market Trends
2.2.2. Market Recommendations
3. Market Determinants
3.1. Market Drivers
3.1.1. Drivers For Anatomical Modelling Market: Impact Analysis
3.2. Market Pain Points and Challenges
3.2.1. Restraints For Anatomical Modelling Market: Impact Analysis
3.3. Market Opportunities
3.3.1. Opportunities For Anatomical Modelling Market: Impact Analysis
4. Competitive Landscape
4.1. Competitive Dashboard – Anatomical Modelling Market Revenue and Share by Manufacturers
Anatomical Modelling Type Comparison Analysis
Top Market Player Ranking Matrix
4.2. Key Company Analysis
4.2.1. 3B Scientific GmbH
4.2.1.1. Overview
4.2.1.2. Product Portfolio
4.2.1.3. Financial Analysis
4.2.1.4. SWOT Analysis
4.2.1.5. Business Strategy
4.2.2. Laerdal Medical AS
4.2.2.1. Overview
4.2.2.2. Product Portfolio
4.2.2.3. Financial Analysis
4.2.2.4. SWOT Analysis
4.2.2.5. Business Strategy
4.2.3. Stratasys Ltd
4.2.3.1. Overview
4.2.3.2. Product Portfolio
4.2.3.3. Financial Analysis
4.2.3.4. SWOT Analysis
4.2.3.5. Business Strategy
4.2.4. GPI Anatomicals
4.2.4.1. Overview
4.2.4.2. Product Portfolio
4.2.4.3. Financial Analysis
4.2.4.4. SWOT Analysis
4.2.4.5. Business Strategy
4.2.5. Erler-Zimmer GmbH & Co. KG
4.2.5.1. Overview
4.2.5.2. Product Portfolio
4.2.5.3. Financial Analysis
4.2.5.4. SWOT Analysis
4.2.5.5. Business Strategy
4.3. Top Winning Strategies by Market Players
4.3.1. Merger and Acquisition
4.3.2. Product Launch
4.3.3. Partnership And Collaboration
5. Anatomical Modelling Market Sales Analysis By Type ($ Million)
5.1. Physical Models
5.2. Digital / Virtual Models
5.3. Services
6. Anatomical Modelling Market Sales Analysis By Models ($ Million)
6.1. Standard Quality Models
6.2. High-Fidelity / Premium Models
6.3. Custom & Patient-Specific Models
7. Anatomical Modelling Market Sales Analysis By End-Use Industry ($ Million)
7.1. Hospitals & Clinics
7.2. Academic Institutions & Education Centers
7.3. Research Centers & Laboratories
7.4. Veterinary Clinics / Animal Health
7.5. Others
8. Regional Analysis
8.1. North American Anatomical Modelling Market Sales Analysis – Type Models End-Use Industry Country ($ Million)
Macroeconomic Factors for North America
8.1.1. United States
8.1.2. Canada
8.2. European Anatomical Modelling Market Sales Analysis – Type Models End-Use Industry Country ($ Million)
Macroeconomic Factors for Europe
8.2.1. UK
8.2.2. Germany
8.2.3. Italy
8.2.4. Spain
8.2.5. France
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Asia-Pacific Anatomical Modelling Market Sales Analysis – Type Models End-Use Industry Country ($ Million)
Macroeconomic Factors for Asia-Pacific
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.3.4. India
8.3.5. Australia & New Zealand
8.3.6. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
8.3.7. Rest of Asia-Pacific
8.4. Rest of the World Anatomical Modelling Market Sales Analysis – Type Models End-Use Industry ($ Million)
Macroeconomic Factors for the Rest of the World
8.4.1. Latin America
8.4.2. Middle East and Africa
9. Company Profiles
9.1. 3D Systems, Inc.
9.1.1. Quick Facts
9.1.2. Company Overview
9.1.3. Product Portfolio
9.1.4. Business Strategies
9.2. A.Algeo Ltd
9.2.1. Quick Facts
9.2.2. Company Overview
9.2.3. Product Portfolio
9.2.4. Business Strategies
9.3. Adam, Rouilly Ltd
9.3.1. Quick Facts
9.3.2. Company Overview
9.3.3. Product Portfolio
9.3.4. Business Strategies
9.4. Anatomage Inc.
9.4.1. Quick Facts
9.4.2. Company Overview
9.4.3. Product Portfolio
9.4.4. Business Strategies
9.5. Anatomy Warehouse
9.5.1. Quick Facts
9.5.2. Company Overview
9.5.3. Product Portfolio
9.5.4. Business Strategies
9.6. Axial3D
9.6.1. Quick Facts
9.6.2. Company Overview
9.6.3. Product Portfolio
9.6.4. Business Strategies
9.7. Columbia Dentoform Teaching Solutions
9.7.1. Quick Facts
9.7.2. Company Overview
9.7.3. Product Portfolio
9.7.4. Business Strategies
9.8. Denoyer-Geppert Science
9.8.1. Quick Facts
9.8.2. Company Overview
9.8.3. Product Portfolio
9.8.4. Business Strategies
9.9. Formlabs
9.9.1. Quick Facts
9.9.2. Company Overview
9.9.3. Product Portfolio
9.9.4. Business Strategies
9.10. Frasaco GmbH
9.10.1. Quick Facts
9.10.2. Company Overview
9.10.3. Product Portfolio
9.10.4. Business Strategies
9.11. Lazarus 3D, LLC
9.11.1. Quick Facts
9.11.2. Company Overview
9.11.3. Product Portfolio
9.11.4. Business Strategies
9.12. Materialise NV
9.12.1. Quick Facts
9.12.2. Company Overview
9.12.3. Product Portfolio
9.12.4. Business Strategies
9.13. Nasco Healthcare
9.13.1. Quick Facts
9.13.2. Company Overview
9.13.3. Product Portfolio
9.13.4. Business Strategies
9.14. Osteo3D
9.14.1. Quick Facts
9.14.2. Company Overview
9.14.3. Product Portfolio
9.14.4. Business Strategies
9.15. Prodont-Holliger
9.15.1. Quick Facts
9.15.2. Company Overview
9.15.3. Product Portfolio
9.15.4. Business Strategies
9.16. Sakamoto Model Corporation
9.16.1. Quick Facts
9.16.2. Company Overview
9.16.3. Product Portfolio
9.16.4. Business Strategies
9.17. Scientific Publishing Ltd
9.17.1. Quick Facts
9.17.2. Company Overview
9.17.3. Product Portfolio
9.17.4. Business Strategies
9.17.5. Business Strategies
9.18. Shanghai Honglian Medical Tech Group
9.18.1. Quick Facts
9.18.2. Company Overview
9.18.3. Product Portfolio
9.18.4. Business Strategies
9.19. Simulaids, Inc.
9.19.1. Quick Facts
9.19.2. Company Overview
9.19.3. Product Portfolio
9.19.4. Business Strategies
9.19.5. Business Strategies
9.20. SOMSO Modelle
9.20.1. Quick Facts
9.20.2. Company Overview
9.20.3. Product Portfolio
9.20.4. Business Strategies
9.21. Xincheng Scientific Industries Co., Ltd
9.21.1. Quick Facts
9.21.2. Company Overview
9.21.3. Product Portfolio
9.21.4. Business Strategies
9.21.5. Business Strategies
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.